Pzena Mid Cap Value Investor holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
Pzena Mid Cap Value Fund Investor Class PZVMX
- NAV / 1-Day Return 13.26 / −0.15 %
- Total Assets 70.7M
-
Adj. Expense Ratio
1.250%
- Expense Ratio 1.240%
- Distribution Fee Level High
- Share Class Type No Load
- Category Mid-Cap Value
- Investment Style Small Value
- Min. Initial Investment 5,000
- Status Open
- TTM Yield 0.02%
- Turnover 31%
USD | NAV as of Oct 03, 2026 | 1-Day Return as of Oct 03, 2026, 12:57 AM GMT+0
Morningstar’s Analysis PZVMX
Will PZVMX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 39.4
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Baxter International Inc | 5.72 | 6M | Healthcare |
Humana Inc | 5.41 | 5M | Healthcare |
Robert Half Inc | 4.71 | 5M | Industrials |
Universal Health Services Inc Class B | 3.66 | 4M | Healthcare |
Advance Auto Parts Inc | 3.57 | 4M | Consumer Cyclical |
Cognizant Technology Solutions Corp Class A | 3.51 | 3M | Technology |
Dollar General Corp | 3.49 | 3M | Consumer Defensive |
Global Payments Inc | 3.25 | 3M | Industrials |
Corebridge Financial Inc | 3.06 | 3M | Financial Services |
Fresenius Medical Care AG ADR | 2.99 | 3M | Healthcare |